The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate…

Overview of attention for article published in Journal of Nuclear Cardiology, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 63,086 followers.

RT @MyASNC: #JNucCard EXERRT trial: Patients with inadequate exercise stress for #SPECT MPI may be safely converted to a pharmacologic tes…

#JNucCard EXERRT trial: Patients with inadequate exercise stress for #SPECT MPI may be safely converted to a pharmacologic test with regadenoson during recovery and have comparable perfusion defects. https://t.co/v2eDW3cOTF #CVNuc #JournalNC https://t.co/

RT @Toaster_Pastry: Study: Safe to administer Lexiscan after failed exercise stress test (99% clinical practice is doing this already). htt…

RT @Toaster_Pastry: Study: Safe to administer Lexiscan after failed exercise stress test (99% clinical practice is doing this already). htt…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.